« Q&A: Philly guns and business | Main | Black tracking »

Stout's consolation prize

The Financial Times says today that David Stout, the Philadelphian who lost the race to become CEO of GlaxoSmithKline PLC (NYSE: GSK), may now be invited to join the GSK board along with the other passed-over executive, Chris Viehbacher. At least we get an answer to our last post on the topic. Ed Silverman at Pharmalot observes it would also change the balance of execs to non-execs on the GSK board.

- Thomas Ginsberg

Tags:

Posted by phillyinc on October 15, 2007 1:44 PM |

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

Contributors

Inquirer staff writers

Special contributors


Search


About

This page contains a single entry from the blog posted on October 15, 2007 1:44 PM.

The previous post in this blog was Q&A: Philly guns and business.

The next post in this blog is Black tracking.

Many more can be found on the main index page or by looking through the archives.

Subscribe to this blog's feed
[What is this?]
Powered by
Movable Type 3.35